153: Hot Flashes Explained: Can Oxybutynin Really Help Prostate Cancer Patients?

19 Visioni

  • Grazie! Condividilo con i tuoi amici!

    Non hai gradito questo video. Grazie per il feedback!

admin
Published
Hot flashes are one of the most common—and disruptive—side effects experienced by men undergoing androgen deprivation therapy (ADT) for prostate cancer. In this episode of UroNurse News, we break down emerging evidence suggesting that oxybutynin, a medication traditionally used for overactive bladder, may significantly reduce the frequency and severity of ADT-associated hot flashes.

Hosted and presented by Vic Senese, RN, BSN, FAUNA, this episode explores:

Why hot flashes occur during androgen deprivation therapy

How oxybutynin works and why it may help with vasomotor symptoms

What recent studies reveal about effectiveness and tolerability

How oxybutynin compares to other hot flash treatments like antidepressants or hormonal agents

Practical clinical considerations for patients and clinicians

If you or someone you care for is struggling with prostate cancer treatment side effects, this discussion offers clear, evidence-based insight into a potential non-hormonal option for symptom relief.

???? Subscribe to the UroNurse channel for weekly urology news, patient education, and clinical insights:
???? https://www.youtube.com/@UroNurse1

???? About UroNurse News
UroNurse News delivers timely, easy-to-understand updates on urology research, prostate cancer care, men’s health, and emerging treatments—bridging the gap between clinical science and real-world practice.

The expert's opinions in this communication are personal and not representative of any organization. They are for informational purposes only, not official guidance. Viewers are advised to use their judgment, seek additional advice, and take responsibility for any actions based on these opinions.
Categoria
Oncology
Commenta per primo questo video.

Prossimo